Krystal Biotech, Inc. logo KRYS - Krystal Biotech, Inc.

NEXT EARNINGS: Feb 17, 2026 (today)
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 16
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $269.25 DETAILS
HIGH: $327.00
LOW: $216.00
MEDIAN: $267.00
CONSENSUS: $269.25
DOWNSIDE: 8.62%
Market Cap: 8.54B
Volume: 840,274
Avg Volume: 286,630
52 Week Range: 122.8-298.3025
Sector: Healthcare
Industry: Biotechnology
Beta: 0.48
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 275
IPO Date: 2017-09-20
EPS (TTM): 7.08
P/E Ratio: 34.84
Revenue (TTM): 389.13M
Total Assets: 1.33B
Total Debt: 1.77M
Cash & Equiv: 496.30M
Rev Growth (5Y): 156.2%
EPS Growth (5Y): 680.0%
FCF Growth (5Y): N/A
ROCE: N/A
Debt/Equity: 0.00

Track Record

Statements >
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 389.13M 290.51M 50.70M N/A N/A N/A N/A 1.03M N/A N/A
Net Income 204.83M 89.16M 10.93M (139.97M) (69.57M) (32.17M) (19.09M) (10.89M) (7.92M) (1.15M)
EPS 7.08 3.12 0.40 -5.49 -3.13 -1.71 -1.20 -0.97 -1.48 -0.27
Total Assets 1.33B 1.06B 818.36M 558.45M 626.29M 310.84M 209.02M 116.12M 50.11M 2.18M
Total Debt 1.77M 7.26M 8.09M 8.93M 8.02M 11.55M 3.26M N/A N/A 1.84M
Cash & Equivalents 496.30M 344.87M 358.33M 161.90M 341.25M 268.27M 187.51M 103.67M 49.59M 1.92M
Operating Cash Flow 200.87M 123.42M (88.80M) (100.57M) (47.94M) (26.08M) (18.71M) (9.45M) (3.89M) (1.31M)
Free Cash Flow 188.91M 119.18M (100.60M) (153.55M) (116.27M) (40.93M) (25.11M) (11.68M) (4.10M) (1.33M)
FCF per Share 6.53 4.17 -3.70 -6.02 -5.24 -2.18 -1.58 -1.04 -0.76 -0.31
Book Value 1.22B 946.38M 778.64M 522.23M 593.58M 292.08M 202.91M 113.23M 49.47M 289,000
Cash & ST Investments 827.79M 597.52M 532.18M 379.17M 438.10M 271.26M 193.69M 111.76M 49.59M 1.92M
ROC Equity 0.17 0.09 0.01 -0.27 -0.12 -0.11 -0.09 -0.10 -0.16 -3.98